Evidence – Harnessing Liquid Biopsy Signals to Advance Early Cancer Detection, MRD Monitoring, & Predictive Disease Modeling

• Translating liquid biopsy insights into preclinical models to detect early tumour evolution and -treatment response
• Modeling Low Tumor Burden and Tumor Developmental Trajectories to Advance Early Cancer -Detection and Therapeutic Index
• Using clinical observational data to refine model systems and enable earlier, more effective intervention strategies

Speakers:

Claudio Murgia

Unit Head, Target & Disease Biology, Discovery Oncology

Roche